Molecular docking of resveratrol with known protein structures as well as high-throughput meta-data analyses uncork the “French Paradox” and its potential “Druggable” targets in humans

BMC Genomics

Poster Presentation

Kalamegam Gauthaman¹  Peter Natesan Pushparaj¹  Sajjad Karim¹  Kothandaraman Narasimhan¹  Mohammed Alqahtani¹  Mamdooh Gari²  Adel Abuzenadah²  Adeel Chaudhary³  Zeenat Mirza⁴ 

[1] Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia;Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia;Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Kingdom of Saudi Arabia;Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia;King Fahd Medical Research Center, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia;King Fahd Medical Research Center, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia;

关键词: Multiple Sclerosis;    Resveratrol;    Diabetic Retinopathy;    Molecular Docking;    Ingenuity Pathway Analysis;   

DOI  :  10.1186/1471-2164-15-S2-P27

来源: Springer

【 授权许可】

CC BY   
© Pushparaj et al; licensee BioMed Central Ltd. 2014